BlackRock Fund Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $13.9M | Buy |
2,372,234
+350,552
| +17% | +$2.05M | ﹤0.01% | 2388 |
|
|
2016
Q3 | $10.7M | Buy |
2,021,682
+136,834
| +7% | +$727K | ﹤0.01% | 2425 |
|
|
2016
Q2 | $12.5M | Sell |
1,884,848
-596,985
| -24% | -$3.95M | ﹤0.01% | 2282 |
|
|
2016
Q1 | $11.6M | Sell |
2,481,833
-87,705
| -3% | -$410K | ﹤0.01% | 2279 |
|
|
2015
Q4 | $13M | Buy |
2,569,538
+109,250
| +4% | +$552K | ﹤0.01% | 2299 |
|
|
2015
Q3 | $8.66M | Sell |
2,460,288
-24,241
| -1% | -$85.3K | ﹤0.01% | 2466 |
|
|
2015
Q2 | $24.8M | Sell |
2,484,529
-125,111
| -5% | -$1.25M | 0.01% | 1978 |
|
|
2015
Q1 | $33.2M | Buy |
2,609,640
+275,752
| +12% | +$3.51M | 0.01% | 1780 |
|
|
2014
Q4 | $33M | Buy |
2,333,888
+346,328
| +17% | +$4.9M | 0.01% | 1757 |
|
|
2014
Q3 | $27.3M | Sell |
1,987,560
-59,814
| -3% | -$822K | 0.01% | 1766 |
|
|
2014
Q2 | $31.5M | Sell |
2,047,374
-454,367
| -18% | -$6.99M | 0.01% | 1724 |
|
|
2014
Q1 | $42.6M | Buy |
2,501,741
+280,436
| +13% | +$4.78M | 0.01% | 1526 |
|
|
2013
Q4 | $28.8M | Sell |
2,221,305
-87,431
| -4% | -$1.13M | 0.01% | 1768 |
|
|
2013
Q3 | $23.3M | Buy |
2,308,736
+270,384
| +13% | +$2.73M | 0.01% | 1867 |
|
|
2013
Q2 | $15.2M | Buy |
+2,038,352
| New | +$15.2M | 0.01% | 2009 |
|